1. Home /
  2. Drug Approvals

Drug Approvals

Here's How I'm Trading XBiotech

Do these shares get back to the 2020 highs that were reached back in January?

Will Mydecine's Move Make the Market for Pharmaceutical Psilocybin Mushroom?

Psychedelic companies hoping to capitalize on a surging interest in psilocybin treatments have been limited to one source for research grade psilocybin. Until now.

BioMarin's FDA Setback Opens New Opportunities for the Stock

A simple covered call strategy seems appropriate here.

Here's How Patient Investors Could Buy Vertex Pharmaceuticals

The short-term charts of VRTX suggest that this stock can see further sideways to lower price action in the weeks ahead.

Back to Back Wins for Bristol-Myers, and Here's How I'd Trade It

BMY sees reason for optimism over the final half of the year.

Let's Not Overlook AbbVie's Q2 Beat

There is no thought of selling here and now, even with politicized pressure on the industry.

Here's My Biotechnology Shopping List

Biotechnology is always high risk but the right plays move unlike anything else.

Totally Out There: Our Top 5 Psychedelic Stocks

Investors are anxious to grab the next penny stock that may be poised to jump on the mind-blowing bubble. Here they are.

A Rally to $21 on Takeda Pharmaceutical Would Be Bullish

Let's review the charts and indicators.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.